Global Infectious Disease Treatment Market Size, Analysis, Share, Research, Growth, Trends, Report, Opportunities and Forecast 2014-2018

1
Global Infectious Disease Treatment Market
2014-2018
Publish By Technovia
Email sales_at_researchbeam.com
Toll Free 1 [phone]
2
Report Overview
About Infectious Disease Treatment Infectious
diseases can be caused by various pathogenic
microorganisms such as bacteria, fungi,
parasites, or viruses. These diseases can be
transmitted from one individual to another
through either direct contact or indirect
contact. Anti-infective drugs are used to kill
(cidal) or stop the growth (static) of infectious
agents. Based on the target organism,
anti-infective drugs can be categorized into
antibacterial, antiviral, antifungal, and
antiparasitic. Anti-infective drugs can act via
host defence system or can directly target the
causative agent. TechNavio's analysts forecast
the Global Infectious Disease Treatment market to
grow at a CAGR of 3.43 percent over the period
2013-2018. Covered in this Report This report
covers the present scenario and the growth
prospects of the Global Infectious Disease
Treatment market for the period 2014-2018. To
calculate the market size, the report considers
the revenue generated through the sales of
various drugs administered to treat various
infectious diseases caused by bacteria, virus,
fungi, and parasites, which include
Antibacterial drugs (beta-lactams, macrolides,
aminoglycosides, phenicols, quinolones,
sulfonamides, tetracyclines, and other
antibacterials)
3
Report Overview
Antiviral drugs (HIV, hepatitis C, hepatitis B,
and other antivirals) Antifungal drugs (azoles,
pyrimidines, echinodians, polyenes, allylamines,
and other antifungal drugs) Antiparasitic
drugs TechNavio's report, the Global Infectious
Disease Treatment Market 2014-2018, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, and the EMEA and APAC
regions it also covers the Global Infectious
Disease Treatment market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market. Get full access of the
report at http//www.researchbeam.com/global-infe
ctious-disease-treatment-2014-2018-market Key
Regions Americas APAC EMEA
4
Report Overview
Key Vendors F. Hoffmann-La Roche Gilead
Sciences GlaxoSmithKline Johnson Johnson
Merck Pfizer Other Prominent Vendors
Achillion Pharmaceuticals AbbVie Astellas
Pharma AstraZeneca Auritec Pharmaceuticals
Bayer Bristol-Myers Squibb Chimerix
Pharmaceuticals Cubist
5
Table Of Content
02. List of Abbreviations 03. Scope of the
Report 03.1 Market Overview 03.2 Product
Offerings 04. Market Research Methodology 04.1
Market Research Process 04.2 Research
Methodology 05. Introduction 06. Market
Landscape 06.1 Market Overview
6
Table Of Content
06.2 Market Size and Forecast 06.3 Five Forces
Analysis 07. Market Segmentation by
Application 08. Global Antibacterial Drugs
Market 08.1 Introduction 08.2 Market Size and
Forecast 08.3 Market Segmentation by Chemical
Class 08.4 Market Segmentation by Drug
Origin 09. Global Antifungal Drugs Market 09.1
Introduction
7
List of Exhibits
Exhibit 1 Market Research Methodology Exhibit
2 Global Infectious Disease Treatment Market
2013-2018 (US million) Exhibit 3 Global
Infectious Disease Treatment Market Segmentation
by Application Exhibit 4 Global Infectious
Disease Treatment Market Segmentation by
Application 2013 Exhibit 5 Global Infectious
Disease Treatment Market Segmentation by
Application 2018 Exhibit 6 Global Infectious
Disease Treatment Market Segmentation by
Application 2013-2018 (US million) Exhibit 7
Global Infectious Disease Treatment Market
Segmentation by Application 2013-2018 Exhibit 8
Snapshot of Global Infectious Disease Treatment
Market Segments 2013-2018 Exhibit 9 YoY Growth
Rate of Global Infectious Disease Treatment
Market Segments 2013-2018 Exhibit 10 Global
Antibacterial Drugs Market Key Drivers and
Challenges
8
List of Exhibits
Exhibit 11 Global Antibacterial Drugs Market
2013-2018 (US million) Exhibit 12 Global
Antibacterial Drugs Market Segmentation by
Chemical Class Exhibit 13 Cephalosporin
Segmentation by Generation of Drugs Exhibit 14
Global Antibacterial Drugs Market Revenue
Segmentation by Chemical Class 2013 Exhibit 15
Global Antibacterial Drugs Market Segmentation by
Chemical Class in Volume 2013 Exhibit 16 Global
Antibacterial Drugs Market Segmentation by Drug
Origin Exhibit 17 Global Antifungal Drugs
Market Key Drivers and Challenges Exhibit 18
Global Antifungal Drugs Market 2013-2018 (US
million) To make an enquiry before purchasing
the report, visit at http//www.researchbeam.com/
global-infectious-disease-treatment-2014-2018-mark
et/purchase-enquiry
9
Contact Us
Direct 1 [phone] Toll Free 1 (855)
711-1555 Fax [phone] Web
www.researchbeam.com Email sales_at_researchbeam.com
Deep 5320 SW Macadam Avenue, Suite 100,
Portland, OR 97239 United States